Meta AnalysisID 6019
中药丹蒌片治疗冠心病的有效性与安全性：随机对照试验的系统评价与Meta分析
CRD42021274916
This study was conducted to evaluate the efficacy and safety of Chinese Herbal Medicine Danlou Tablet on Coronary heart disease.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6019
- Evidence Id
- 14577
- Core Evidence Id
- 14577
- Source Meta Analysis Id
- 6002
- Herb2 Meta Analysis Id
- HBMA006002
- Crd Id
- CRD42021274916
- Title
- The Efficacy and Safety of Chinese Herbal Medicine Danlou Tablet in the Treatment of Coronary heart disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Review Question
- This study was conducted to evaluate the efficacy and safety of Chinese Herbal Medicine Danlou Tablet on Coronary heart disease.
- Study Type Included
- Randomized controlled trials
- Condition Being Studied
- Coronary heart disease (CHD) is a common cardiovascular disease in clinic, which causes serious negative impact on patients' life and health. More and more studies show that Chinese medicine plays an important role in the treatment of cardiovascular diseases. Some studies have confirmed the advantages of Chinese Herbal Medicine Danlou Tablet in the treatment of Coronary heart disease and can enhance the efficacy of western medicines, but there is a lack of reliable evidence-based evidence.
- Participant
- The patient meets the diagnostic criteria for Coronary heart disease (CHD).
- Animal
- Human Disease Modelled
- Intervention
- Oral Danlou Tablet or a combination of western medicine, there is no limitation for the intervention duration and frequency
- Comparator Control
- Oral western medicine were the same as those in the treatment group or placebo control.
- Main Outcome
- Total efficiency Measures of effect Relative risks
- Outcome Measure
- Additional Outcome
- TCM syndrome score；ECG；Hemorheological parameters；Incidence of adverse reactions. Measures of effect Standardized mean difference;Relative risks
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- Coronary Disease; Drugs, Chinese Herbal; Humans; Phytotherapy; Randomized Controlled Trials as Topic; danlou tablet
- Contact
- WeiLi Mao [email protected]
- Organisational Affiliation
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital
- Funding Source
- This research was supported by Zhejiang Provincial Natural Science Foundation of China under Grant Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> No. LYQ20H300001
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2021-08-23
- Registration Date
- 2021-09-22
- Anticipated Start Date
- 2021-08-21
- Anticipated Completion Date
- 2022-10-31
- Title Cn
- 中药丹蒌片治疗冠心病的有效性与安全性：随机对照试验的系统评价与Meta分析
- Title En
- The Efficacy and Safety of Chinese Herbal Medicine Danlou Tablet in the Treatment of Coronary heart disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Bilingual Status
- complete